Pulse Biosciences PLSE
$ 17.63
9.37%
Quarterly report 2024-Q3
added 10-30-2024
Country |
USA |
IPO year |
2016 |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Darrin R. Uecker |
Employees in the company |
82 |
Shares |
48 M |
Market Cap[1] |
$ 847 M |
EBITDA (LTM) |
$ -46.8 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Medical instruments"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.